GlassScriptPhysician profile
Marila Taylor
NPI 1124225818
$1,248.37
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,062 · 2022: $187.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $418.22 | 2021-2022 | |
| Galderma Laboratories, L.P. | $304.51 | 2021 | |
| Glaxosmithkline, LLC. | $221.73 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.50 | 2021 | |
| Advanced Respiratory, INC | $63.88 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $54.43 | 2021-2022 | |
| Grifols USA, LLC | $35.58 | 2021-2022 | |
| Baxter Healthcare | $29.52 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marila Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.